Bingli · Company in Belgium Tech

Overview

Founded in 2017 in Antwerp, Bingli builds an AI-powered anamnesis platform that replaces paper intake forms with an adaptive digital conversation. Before a consultation, patients answer an AI-guided questionnaire that dynamically adapts based on their responses, producing a structured medical summary for the physician. The goal is to reduce consultation overhead and improve diagnostic quality.

With EUR 5.4M from Capricorn Partners and pharmaceutical company UCB, Bingli has strong institutional backing in the Belgian life sciences and digital health ecosystem. UCB's involvement signals potential for integration with pharmaceutical and clinical research workflows beyond primary care.

Funding history

Series A: EUR 5.4M from Capricorn Partners and UCB

Key people

PTom Van De Putte

In the news

Bingli expands its partnership with Schmitt-Thompson Clinical Content to bring real-time ambient AI to nurse-led telephone triage Bingli is excited to announce the next phase of our partnership with Schmitt-Thompson Clinical Content (STCC). Together, we've developed a clinically governed ambient AI solution that combines real-time conversational intelligence with STCC's trusted evidence-based triage protocols. Bingli's ambient listening platform has been designed to address these workflow challenges without changing the underlyingLinkedIn · 16 Jul 2026

Alumni 1 went on to found or lead

Quinten RosseelData Scientist→Co-Founder at Ella Energy AI

Backers

UCB
UCB is a Brussels-based global biopharmaceutical company listed on Euronext Brussels, focused on neurology and immunology medicines.
Capricorn Partners
Leuven-based VC with EUR 300M+ AUM, investing in cleantech, digital, health, and fusion technology with over 30 years of experience.

Something wrong or missing? Send an update. Fixed within 24 hours.